Mostra i principali dati dell'item
dc.contributor.author | Sereno, María | |
dc.contributor.author | Jimenez Gordo, Ana María | |
dc.contributor.author | Baena Espinar, Javier | |
dc.contributor.author | Aguado, Carlos | |
dc.contributor.author | Mielgo, Xabier | |
dc.contributor.author | Pertejo, Ana | |
dc.contributor.author | Álvarez Álvarez, Rosa | |
dc.contributor.author | Sánchez, Ana | |
dc.contributor.author | López, Jose Luis | |
dc.contributor.author | Molina, Raquel | |
dc.contributor.author | López Alfonso, Ana | |
dc.contributor.author | Hernández, Berta | |
dc.contributor.author | Enrique Chiara, Luis | |
dc.contributor.author | Martín, Ana Manuela | |
dc.contributor.author | López Martín, Ana![]() |
|
dc.contributor.author | Dorta, Miriam | |
dc.contributor.author | Collazo Lorduy, Ana | |
dc.contributor.author | Casado, Enrique | |
dc.contributor.author | Ramirez de Molina, Ana | |
dc.contributor.author | Colmenarejo, Gonzalo | |
dc.date.accessioned | 2024-02-05T09:20:39Z | |
dc.date.available | 2024-02-05T09:20:39Z | |
dc.date.created | 2021-08 | |
dc.date.issued | 2021-08 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12080/39499 | |
dc.description.abstract | Infections with COVID-19 in neutropenic cancer patients are related to poor outcomes. A G-CSF treatment used in neutropenic cancer with SARS-CoV-2 infections is related to a higher rate of respiratory failure according to progressive and growing evidence. In this small retrospective non-randomized study, we found an association between G-CSF treatment and the parameters predisposing for worse infections with COVID-19 and neutropenia compared with patients not treated with G-CSF. We also found that the number of days on G-CSF treatment was related to a higher risk of mortality in a multivariable analysis among patients treated with G-CSF. | es_ES |
dc.format | application/pdf | es_ES |
dc.language | eng | es_ES |
dc.rights | CC-BY | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.es | es_ES |
dc.title | A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | es_ES |
dc.identifier.location | N/A | es_ES |